A key contribution of this work is the identification of multi-omic regulatory biomarkers linking genomic variants (SNPs), DNA methylation sites, and gene expression that are significantly correlated with plasma p-Tau181 levels, a clinically validated marker of tau pathology and cognitive decline. Here, MAPT is linked to Mental deterioration.